In the last trading session, 3.29 million Tenaya Therapeutics Inc (NASDAQ:TNYA) shares changed hands as the company’s beta touched 3.01. With the company’s per share price at $0.49 changed hands at $0.03 or 6.64% during last session, the market valuation stood at $79.89M. TNYA’s last price was a discount, traded about -912.24% off its 52-week high of $4.96. The share price had its 52-week low at $0.39, which suggests the last value was 20.41% up since then. When we look at Tenaya Therapeutics Inc’s average trading volume, we note the 10-day average is 1.57 million shares, with the 3-month average coming to 3.34 million.
Analysts gave the Tenaya Therapeutics Inc (TNYA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TNYA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Tenaya Therapeutics Inc’s EPS for the current quarter is expected to be -0.2.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Instantly TNYA was in green as seen at the end of in last trading. With action 9.16%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -65.65%, with the 5-day performance at 9.16% in the green. However, in the 30-day time frame, Tenaya Therapeutics Inc (NASDAQ:TNYA) is -23.42% down. Looking at the short shares, we see there were 8.77 million shares sold at short interest cover period of 3.27 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -15.48%. The 2025 estimates are for Tenaya Therapeutics Inc earnings to increase by 45.89%.
TNYA Dividends
Tenaya Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-09.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.77% of Tenaya Therapeutics Inc shares while 57.55% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 58.00%. There are 57.55% institutions holding the Tenaya Therapeutics Inc stock share, with COLUMN GROUP LLC the top institutional holder. As of 2024-06-30, the company held 10.968% of the shares, roughly 9.4 million TNYA shares worth $29.14 million.
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 8.8935% or 7.62 million shares worth $23.63 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.06 shares estimated at $1.01 million under it, the former controlled 1.27% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 0.90% of the shares, roughly 1.46 shares worth around $0.72 million.
